Basic Materials -
Chemicals - Specialty - NYSE - US
$ 48.14
-3.12 %
$ 2.27 B
Market Cap
-25.61
P/E
1. INTRINSIC VALUE
Balance Sheet
Ashland Inc.
| Current Assets | 1.2 B |
| Cash & Short-Term Investments | 300 M |
| Receivables | 243 M |
| Other Current Assets | 652 M |
| Non-Current Assets | 4.45 B |
| Long-Term Investments | 3 M |
| PP&E | 1.42 B |
| Other Non-Current Assets | 3.03 B |
| Current Liabilities | 490 M |
| Accounts Payable | 214 M |
| Short-Term Debt | 20 M |
| Other Current Liabilities | 256 M |
| Non-Current Liabilities | 2.29 B |
| Long-Term Debt | 1.45 B |
| Other Non-Current Liabilities | 839 M |
EFFICIENCY
Earnings Waterfall
Ashland Inc.
| Revenue | 2.11 B |
| Cost Of Revenue | 1.5 B |
| Gross Profit | 618 M |
| Operating Expenses | 644 M |
| Operating Income | -26 M |
| Other Expenses | -195 M |
| Net Income | 169 M |
RATIOS
FREE CASH FLOW ANALYSIS
Free Cash Flow Analysis
Ashland Inc.
| Net Income | 169 M |
| Depreciation & Amortization | 329 M |
| Capital Expenditures | -137 M |
| Stock-Based Compensation | 15 M |
| Change in Working Capital | 227 M |
| Others | 76 M |
| Free Cash Flow | 325 M |
Wall Street Analysts Price Targets
Ashland Inc.
Wall Street analysts predict an average 1-year price target for ASH of $88.2 , with forecasts ranging from
a
low of
$60 to a high of $110 .
ASH Lowest Price Target
Wall Street Target
60 USD
24.64%
ASH Average Price Target
Wall Street Target
88.2 USD
83.15%
ASH Highest Price Target
Wall Street Target
110 USD
128.50%
4. DIVIDEND
ANALYSIS
0.68%
DIVIDEND YIELD
0.405 USD
DIVIDEND PER SHARE
5. COMPETITION
6. Ownership
Insider Ownership
Ashland Inc.
Sold
0-3 MONTHS
0 USD 0
3-6 MONTHS
115 K USD 2
6-9 MONTHS
482 K USD 1
9-12 MONTHS
0 USD 0
Bought
0 USD 0
0-3 MONTHS
2.21 M USD 2
3-6 MONTHS
0 USD 0
6-9 MONTHS
0 USD 0
9-12 MONTHS
7. News
Ashland board authorizes quarterly dividend
WILMINGTON, Del., May 06, 2025 (GLOBE NEWSWIRE) -- The board of directors of Ashland Inc. (NYSE: ASH) has declared a quarterly cash dividend of $0.415 cents per share on the company's common stock which represents a 2.5 percent increase from the previous quarter.
globenewswire.com
- 1 week ago
Ashland's Q2 Earnings and Revenues Miss Estimates, Down Y/Y
ASH's fiscal second-quarter sales are adversely impacted by the portfolio optimization actions.
zacks.com
- 1 week ago
Ashland announces executive leadership changes
WILMINGTON, Del., May 05, 2025 (GLOBE NEWSWIRE) -- Ashland Inc. (NYSE: ASH) announced today that Kevin Willis, senior vice president and chief financial officer, has decided to leave Ashland to pursue another opportunity. His last day with the company will be May 16, 2025.
globenewswire.com
- 2 weeks ago
Ashland, Inc. (ASH) Q2 2025 Earnings Call Transcript
Ashland, Inc. (NYSE:ASH ) Q2 2025 Earnings Conference Call May 1, 2025 10:00 AM ET Company Participants William Whitaker - VP, Finance & Director, IR Guillermo Novo - Chairman & CEO John Willis - SVP, CFO & Principal Accounting Officer Alessandra Faccin - SVP and GM, Life Sciences and Intermediates James Minicucci - SVP & GM, Personal Care Dago Caceres - SVP & General Manager, Specialty Additives Conference Call Participants Kevin Estok - Jefferies Bhavesh Lodaya - BMO Capital Markets Jeff Zekauskas - JPMorgan David Begleiter - Deutsche Bank Josh Spector - UBS Michael Sison - Wells Fargo John Roberts - Mizuho Mike Harrison - Seaport Research Partners Operator Hello, and welcome to Ashland's Second Quarter Fiscal Year 2025 Earnings Conference Call and Webcast. [Operator Instructions] I would now like to turn the conference over to William Whitaker.
seekingalpha.com
- 2 weeks ago
Ashland (ASH) Q2 Earnings: How Key Metrics Compare to Wall Street Estimates
The headline numbers for Ashland (ASH) give insight into how the company performed in the quarter ended March 2025, but it may be worthwhile to compare some of its key metrics to Wall Street estimates and the year-ago actuals.
zacks.com
- 2 weeks ago
Ashland (ASH) Lags Q2 Earnings and Revenue Estimates
Ashland (ASH) came out with quarterly earnings of $0.99 per share, missing the Zacks Consensus Estimate of $1.10 per share. This compares to earnings of $1.27 per share a year ago.
zacks.com
- 2 weeks ago
Ashland reports second quarter fiscal 2025 results and revises full-year outlook
WILMINGTON, Del., April 30, 2025 (GLOBE NEWSWIRE) -- Ashland Inc. (NYSE: ASH) today announced financial results1 for the second quarter of fiscal year 2025, which ended March 31, 2025, and revised its full-year fiscal 2025 outlook. Ashland, a global additives and specialty ingredients company, holds leadership positions in high-quality, consumer-focused markets including pharmaceuticals, personal care and architectural coatings.
globenewswire.com
- 2 weeks ago
Ashland Place Completes Two New Financing Facilities for Sirius Aviation Capital
NEW YORK , April 29, 2025 /PRNewswire/ -- Ashland Place Finance LLC ("Ashland Place"), a commercial aviation financing platform, today announced the completion of two new facilities for Sirius Aviation Capital Holdings Limited ("Sirius"), a global aircraft lessor based in Abu Dhabi Global Market. Both A320-200s, the aircraft are currently operating on lease to ANA's Peach Aviation Limited ("Peach") in Japan and Controladora Vuela Compañía de Aviación, S.A.B.
prnewswire.com
- 2 weeks ago
Earnings Preview: Ashland (ASH) Q2 Earnings Expected to Decline
Ashland (ASH) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
zacks.com
- 3 weeks ago
Ashland sets date for second-quarter fiscal 2025 earnings release and conference call webcast
WILMINGTON, Del., April 17, 2025 (GLOBE NEWSWIRE) -- Ashland Inc. (NYSE: ASH) today announced plans to issue its second-quarter fiscal 2025 earnings release at approximately 5 p.m. ET on Wednesday, April 30, 2025. The company's live webcast with securities analysts will include an executive summary and detailed remarks. The live webcast will take place at 10 a.m. ET on Thursday, May 1. Simultaneously, the company will post a slide presentation in the Investor Relations section of its website at http://investor.ashland.com.
globenewswire.com
- 1 month ago
Ashland Wraps Up Expansion of Pharmaceutical Plant in Brazil
ASH is investing in modernizing equipment for microbial protection in personal care applications at its Technical Center in Sao Paulo.
zacks.com
- 1 month ago
Ashland expands pharmaceutical plant for Aquarius™ tablet coatings and commissions new microbial protection capability in Brazil, demonstrating strategy to globalize, innovate, and invest
Increased production capacity and market presence expected to drive competitive position and organic growth; follows previous investments in Ireland and China Increased production capacity and market presence expected to drive competitive position and organic growth; follows previous investments in Ireland and China
globenewswire.com
- 1 month ago
8. Profile
Summary
Ashland Inc. ASH
COUNTRY
US
INDUSTRY
Chemicals - Specialty
MARKET CAP
$ 2.27 B
Dividend Yield
0.68%
Description
Ashland Inc. provides additives and specialty ingredients worldwide. It operates through Life Sciences; Personal Care & Household; Specialty Additives; and Intermediates and Solvents segments. The Life Sciences segment offers pharmaceutical solutions, including controlled release polymers, disintegrants, tablet coatings, thickeners, solubilizers, and tablet binders; nutrition solutions, such as thickeners, stabilizers, emulsifiers, and additives; and nutraceutical solutions comprising products for weight management, joint comfort, stomach and intestinal health, sports nutrition, and general wellness, as well as custom formulation, toll processing, and particle engineering solutions. The Personal Care & Household segment provides a range of nature-based, biodegradable, and performance ingredients; solutions for toothpastes, mouth washes and rinses, denture cleaning, and care for teeth; and household supplies nature-derived rheology ingredients, biodegradable surface wetting agents, performance encapsulates, and specialty polymers. The Specialty Additives segment offers rheology modifiers, foam control agents, surfactants and wetting agents, pH neutralizers, advanced ceramics used in catalytic converters, environmental filters, ingredients for the manufacturing of ceramic capacitors, plasma display panels and solar cells, ingredients for textile printing, thermoplastic metals, and alloys for welding. The Intermediates and Solvents segment produces 1,4 butanediol and related derivatives, including n-methylpyrrolidone. It offers its products to customers in a range of consumer and industrial markets, such as architectural coatings, construction, energy, food and beverage, nutraceuticals, personal care, and pharmaceutical. The company was formerly known as Ashland Global Holdings Inc. Ashland Inc. was founded in 1924 and is based in Wilmington, Delaware.
Contact
8145 Blazer Drive, Wilmington, DE, 19808
https://www.ashland.com
IPO
Date
March 17, 1980
Employees
3200
Officers
Carolmarie C. Brown
Vice President of Corporate Affairs, Global Marketing, Brand & Business Communications
Dr. Osama M. Musa Ph.D.
Senior Vice President & Chief Technology Officer
Ms. Alessandra Faccin Assis
Senior Vice President and GM of Life Sciences & Intermediates
Mr. John Kevin Willis
Senior Vice President, Chief Financial Officer & Principal Accounting Officer
Mr. William C. Whitaker C.F.A.
Vice President of Finance & Director of Investor Relations
Mr. James P. Minicucci
Senior Vice President & GM of Personal Care
Ms. Robin E. Lampkin
Senior Vice President, General Counsel & Secretary
Mr. Guillermo Novo
Chairman & Chief Executive Officer
Ms. Eileen M. Drury
Senior Vice President & Chief HR Officer
Mr. Karl R. Bostaph
Senior Vice President of Operations